Veradermics, Incorporated (NYSE:MANE – Get Free Report) shares saw an uptick in trading volume on Wednesday . Citigroup raised their target price on Veradermics from $135.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, July 16th. Lifesci Capital assumed coverage on shares of Veradermics in a research report on Tuesday, June 16th. Based on data from MarketBeat, Veradermics presently has an average rating of “Moderate Buy” and an average price target of $153.00. Veradermics (NYSE:MANE – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th.